Does Rallies show 13F holders for BJDX?

Yes. Rallies tracks hedge fund and 13F ownership data for BJDX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BJDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BJDX. It does not provide personalized investment advice.

BJDX (Bluejay Diagnostics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of May 21, 2026, BJDX trades at $1.67 with a market cap of $1.78M and a P/E ratio of -0.11. BJDX moved +0.00% today. Year to date, BJDX is -32.95%; over the trailing twelve months it is -76.73%. Its 52-week range spans $1.62 to $49.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BJDX stock?

Hedge funds tracked by Rallies that own BJDX include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bluejay Diagnostics, Inc. Common Stock.

BJDX Key Metrics

Key financial metrics for BJDX
Metric	Value
Price	$1.67
Market Cap	$1.78M
P/E Ratio	-0.11
EPS	$-15.25
Dividend Yield	0.00%
52-Week High	$49.80
52-Week Low	$1.62
Volume	103
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-6.85M
Gross Margin	0.00%

Top Hedge Funds Holding BJDX

Renaissance Technologies holds 137.00K shares of BJDX, changed +701.17% as of Sep 30, 2024.
Citadel Advisors holds 52.18K shares of BJDX, changed +162.81% as of Sep 30, 2024.

Latest BJDX News

Bluejay Diagnostics Enrolls 680 of 750 Patients, Bolsters Symphony Manufacturing Readiness — May 7, 2026
Bluejay Diagnostics Reports $5.2M Cash, Advances SYMON II Sepsis Test Study — Mar 6, 2026
Bluejay Diagnostics Tops 545-Patient Enrollment and Secures Capacity for 10M Test Cartridges — Feb 17, 2026

Recent BJDX Insider Trades

Wurth Douglas Clark bought 12.50K (~$25.00K) on Mar 14, 2026.
Dey Indranil bought 12.50K (~$25.00K) on Mar 14, 2026.
CHASE DONALD R bought 12.50K (~$25.00K) on Mar 14, 2026.

BJDX Analyst Consensus

BJDX analyst coverage data. Average price target: $0.00.

Common questions about BJDX

Who owns BJDX stock?: Hedge funds tracked by Rallies that own BJDX include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bluejay Diagnostics, Inc. Common Stock.
Does Rallies show 13F holders for BJDX?: Yes. Rallies tracks hedge fund and 13F ownership data for BJDX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BJDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BJDX. It does not provide personalized investment advice.